TRIAMCINOLONE ACETONIDE TRIAMCINOLONE ACETONIDE QUAGEN PHARMACEUTICALS LLC FDA Approved Triamcinolone Acetonide Lotion, USP is supplied in the following strengths: 0.025%, 0.1%. Each mL of Triamcinolone Acetonide Lotion, USP, 0.025%, 0.1% contains 0.25 mg, 1 mg triamcinolone acetonide, USP in a lotion base containing citric acid, cetyl alcohol, dimethicone, polysorbate 20, propylene glycol, purified water, sorbitan monopalmitate, and stearyl alcohol. It may contain 10% citric acid solution or 10% sodium citrate solution for pH adjustment. Triamcinolone Acetonide is a topical corticosteroid known chemically as 9-Fluoro-11β, 16α, 17, 21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone. The molecular formula is C 24 H 31 FO 6 . It has the following structure: image description
FunFoxMeds bottle
Route
TOPICAL
Applications
ANDA213559

Drug Facts

Composition & Profile

Strengths
0.025 % 60 ml 0.1 %
Quantities
60 ml
Treats Conditions
Indications And Usage Topical Corticosteroids Are Indicated For The Relief Of The Inflammatory And Pruritic Manifestations Of Corticosteroid Responsive Dermatoses

Identifiers & Packaging

Container Type BOTTLE
UPC
0370752130059 0370752129053
UNII
F446C597KA
Packaging

HOW SUPPLIED Triamcinolone Acetonide Lotion, USP 0.025% is supplied in the following size: 60 mL. (NDC 70752-129-05). Triamcinolone Acetonide Lotion, USP 0.1% is supplied in the following size: 60 mL. (NDC 70752-130-05). Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. AVOID FREEZING SHAKE WELL BEFORE USING; PRINCIPAL DISPLAY PANEL NDC 70752- 129 -05 Triamcinolone Acetonide Lotion, USP 0.025% Rx only 60 mL Container Label PRINCIPAL DISPLAY PANEL NDC 70752 -129- 05 Triamcinolone Acetonide Lotion, USP 0.025% Rx only 60 mL Carton PRINCIPAL DISPLAY PANEL NDC 70752- 130 -05 Triamcinolone Acetonide Lotion, USP 0.1% Rx only 60 mL Container Label PRINCIPAL DISPLAY PANEL NDC 70752- 130 -05 Triamcinolone Acetonide Lotion, USP 0.1% Rx only 60 mL Carton containerpoint025percent cartonpoint025percent containerpoint1percent cartonpoint1percent

Package Descriptions
  • HOW SUPPLIED Triamcinolone Acetonide Lotion, USP 0.025% is supplied in the following size: 60 mL. (NDC 70752-129-05). Triamcinolone Acetonide Lotion, USP 0.1% is supplied in the following size: 60 mL. (NDC 70752-130-05). Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. AVOID FREEZING SHAKE WELL BEFORE USING
  • PRINCIPAL DISPLAY PANEL NDC 70752- 129 -05 Triamcinolone Acetonide Lotion, USP 0.025% Rx only 60 mL Container Label PRINCIPAL DISPLAY PANEL NDC 70752 -129- 05 Triamcinolone Acetonide Lotion, USP 0.025% Rx only 60 mL Carton PRINCIPAL DISPLAY PANEL NDC 70752- 130 -05 Triamcinolone Acetonide Lotion, USP 0.1% Rx only 60 mL Container Label PRINCIPAL DISPLAY PANEL NDC 70752- 130 -05 Triamcinolone Acetonide Lotion, USP 0.1% Rx only 60 mL Carton containerpoint025percent cartonpoint025percent containerpoint1percent cartonpoint1percent

Overview

Triamcinolone Acetonide Lotion, USP is supplied in the following strengths: 0.025%, 0.1%. Each mL of Triamcinolone Acetonide Lotion, USP, 0.025%, 0.1% contains 0.25 mg, 1 mg triamcinolone acetonide, USP in a lotion base containing citric acid, cetyl alcohol, dimethicone, polysorbate 20, propylene glycol, purified water, sorbitan monopalmitate, and stearyl alcohol. It may contain 10% citric acid solution or 10% sodium citrate solution for pH adjustment. Triamcinolone Acetonide is a topical corticosteroid known chemically as 9-Fluoro-11β, 16α, 17, 21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone. The molecular formula is C 24 H 31 FO 6 . It has the following structure: image description

Indications & Usage

Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Dosage & Administration

Topical corticosteroids are generally applied to the affected area as a thin film from three to four times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

Warnings & Precautions
No warnings available yet.
Contraindications

Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Adverse Reactions

The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Perioral dermatitis Itching Allergic contact dermatitis Irritation Maceration of the skin Dryness Secondary infection Folliculitis Skin Atrophy Hypertrichosis Striae Acneiform eruptions Miliaria Hypopigmentation


Similar Drugs

Related medications based on brand, generic name, substance, active ingredients.

View all similar drugs →